Literature DB >> 8700653

Reliability and validity of the 12-minute distance walk in patients with chronic obstructive pulmonary disease.

J L Larson1, M K Covey, C A Vitalo, C G Alex, M Patel, M J Kim.   

Abstract

Validity and test-retest liability of the 12-minute distance (12MD) walk, a measure of functional status, were examined in patients with chronic obstructive pulmonary disease. Four tests were administered at weekly intervals. Performance increased (p < .01) over the first three tests. Test-retest reliability was r34 = .98 (df = 46) for tests 3 and 4. The 12MD walk correlated with the Sickness Impact Profile, Physical Dimension (r = -.45); forced expiratory volume in 1 second % predicted ( r = .40); maximal inspiratory pressure (PImax) (r = .52); and exercise-related breathlessness (r = -.49). Exercise-related breathlessness and PImax accounted for 42% of the variance. The validity and reliability of the 12MD walk were supported.

Entities:  

Mesh:

Year:  1996        PMID: 8700653     DOI: 10.1097/00006199-199607000-00003

Source DB:  PubMed          Journal:  Nurs Res        ISSN: 0029-6562            Impact factor:   2.381


  3 in total

1.  Validity and reliability of the 2-minute walk test in individuals with spinal cord injury.

Authors:  Romina Willi; Mario Widmer; Nora Merz; Caroline H G Bastiaenen; Björn Zörner; Marc Bolliger
Journal:  Spinal Cord       Date:  2022-08-23       Impact factor: 2.473

2.  Impact of a walking intervention on cardiorespiratory fitness, self-reported physical function, and pain in patients undergoing treatment for solid tumors.

Authors:  Kathleen Griffith; Jennifer Wenzel; JingJing Shang; Carol Thompson; Kerry Stewart; Victoria Mock
Journal:  Cancer       Date:  2009-10-15       Impact factor: 6.860

Review 3.  Functional Status Assessment of Patients With COPD: A Systematic Review of Performance-Based Measures and Patient-Reported Measures.

Authors:  Yang Liu; Honghe Li; Ning Ding; Ningning Wang; Deliang Wen
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.